文献速递腹部技术与安全CTMR

从实验室到临床:人工智能检测胰腺癌迈向真实世界转化的路径

From Bench to Bedside: The Path Toward Real-World Translation for Artificial Intelligence in Pancreatic Cancer Detection.
PubMed 文献 · Korean J Radiol · 2026-01-01

本文综述了人工智能在胰腺癌检测中的研究现状。AI模型可识别放射科医生难以察觉的影像学细微癌前改变,有望实现更早、更一致的胰腺癌检出。然而,现有模型在多机构间的可重复性和泛化能力不足,前瞻性验证匮乏,工作流程整合、经济限制与模型持续监测等实际问题尚未解决,真实世界落地仍受限。

要点

  • AI可识别胰腺癌诊断前影像中肉眼难以察觉的细微改变,辅助早期检出。
  • 现有模型的跨机构可重复性与泛化能力不足,前瞻性验证研究稀缺。
  • 临床转化还需解决工作流程整合、经济成本和模型持续监测等非模型因素。

核心结论

  • AI在胰腺癌检测中展现出识别放射科医生不可见癌前影像改变的潜力,但真实世界实施仍受可重复性、泛化性、前瞻性验证不足及工作流程、经济与监测等实际问题制约。

研究设计与样本

  • 本文为综述性文章,系统回顾人工智能用于胰腺癌检测的当前研究状态,并梳理阻碍临床转化的模型外障碍。

临床应用与阅片要点

  • AI模型可辅助识别胰腺癌诊断前的细微影像学改变,有望提升早期检出与诊断一致性。
  • 阅片时需意识到AI模型在不同机构间泛化能力有限,不可直接跨机构套用。

局限性

  • 多数模型在多机构间的可重复性和泛化能力不足,且仅少数经过前瞻性验证。
  • 工作流程整合、经济约束与模型持续监测等实际问题尚未解决。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Patients with pancreatic cancer have low survival rates, largely because patients are diagnosed at an advanced stage. Current strategies for early detection, including imaging, blood tests, and genetic sequencing, have limited performance. Recent advances in artificial intelligence (AI) have shown that AI models can identify subtle pre-diagnostic imaging changes that may not be visible to radiologists, raising the possibility of earlier and more consistent pancreatic cancer detection. Despite this progress, real-world implementation of AI for pancreatic cancer detection remains limited. Most models struggle with reproducibility and generalizability across different institutions. Few have undergone prospective validation, and practical issues such as workflow integration, financial constraints, and continuous model monitoring remain unresolved. This article reviews the current state of AI for pancreatic cancer detection and outlines barriers beyond model specifics that must be addressed to enable clinical translation.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Syailendra EA, Arshad H, Lopez-Ramirez F, et al. From Bench to Bedside: The Path Toward Real-World Translation for Artificial Intelligence in Pancreatic Cancer Detection. Korean J Radiol. 2026. PMID: 42225574. doi:10.3348/kjr.2026.0003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。